Abstract
From December 2019 onwards, corona virus disease 2019 (COVID-19) has become a global pandemic caused by the highly transmissible severe acute respiratory syndrome corona virus 2 (SARS-CoV-2). Although ocular manifestations in humans are mild and rare, the route of infection through ocular secretions is currently unknown, and it remains unclear how SARS-CoV-2 penetrates into the ocular secretions 1, 2 . Probable theories include direct inoculation of the ocular tissues from respiratory droplets or aerosolized viral particles, migration from the nasopharynx via the nasolacrimal duct,or even hematogenous spread through the lacrimal gland. Patients invaded with SARS-CoV-2 can present with symptoms of conjunctivitis, including eye redness, ocular irritation, foreign body sensation, tearing and chemosis or swelling of eyelids 4,5 . There have been no reports of COVID-19 patients experiencing blurred vision, subconjunctival hemorrhage, eyelid ecchymoses, conjunctival scarring, keratitis, or pseudomembrane formation. Patients who have acquired the new coronavirus may have ocular symptoms. Conjunctivitis is an inflammation of the membrane covering the eyeball. It is often referred to as ‘pink eye’. Viral conjunctivitis is known to present with upper respiratory infections (colds, flu, etc.) and may be a symptom of the COVID-19. A recent global study reveals that “conjunctival congestion” or “red eye” can lead to a confirmed diagnosis of COVID-19 infection 9,10 . The present Case study shows the confirmed diagnosis of covid-19 infection with Red Eye or Conjunctivitis as the main symptom of presentation. Based on this information, the occurrence of conjunctivitis is low as compare to other systemic manifestation of Covid-19
infections.
Keywords